S 5002
117th Congress
Senate
Health
Animal protection and human-animal relationships
Drug safety, medical device, and laboratory regulation
Medical research
Prescription drugs
Research and development
FDA Modernization Act 2.0
Everywhere this bill has been
6 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 29, 2022
Held at the desk.
Sep 29, 2022
Message on Senate action sent to the House.
Sep 29, 2022
Received in the House.
Sep 29, 2022
Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent. (consideration: CR S5514-5515; text: CR S5514-5515)
Sep 29, 2022
Passed/agreed to in Senate: Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Unanimous Consent.
Sep 29, 2022
Introduced in Senate
Plain-English summary
FDA Modernization Act 2.0
This bill authorizes the use of certain alternatives to animal testing, including cell-based assays and computer models, to obtain an exemption from the Food and Drug Administration to investigate the safety and effectiveness of a drug.
The bill also removes a requirement to use animal studies as part of the process to obtain a license for a biological product that is biosimilar or interchangeable with another biological product.
What's happening now
Held at the desk.